Nexien BioPharma, Inc. (NXEN)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
Market Cap7.08K -99.6%
Revenue (ttm)n/a
Net Income-188.08K
EPS-0.00
Shares Out70.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume115,000
Average Volume44,423
Open0.0018
Previous Close0.0001
Day's Range0.0001 - 0.0018
52-Week Range0.0001 - 0.0145
Beta-1.08
RSI39.26
Earnings DateFeb 17, 2026

About Nexien BioPharma

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado. [Read more]

Sector Healthcare
CEO Richard Greenberg
Country United States
Stock Exchange OTCMKTS
Ticker Symbol NXEN
Full Company Profile

Financial Performance

Financial Statements